Igor I. Slukvin, PhD, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Igor I. Slukvin, PhD, MD, earned his medical degree from Kiev Medical University in Ukraine and completed his residency at UW Hospital and Clinics.
UW School of Medicine and Public Health
|Department of Pathology and Laboratory Medicine|
Professional Certifications and Education
Anatomic Pathology & Clinical Pathology
University of Wisconsin Hospital and Clinics, Madison, WI
Kiev Medical University, Ukraine, 1984
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Suknuntha K Thita T Togarrati PP Ratanachamnong P Wongtrakoongate P Srihirun S Slukvin I Hongeng S .
Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. Int J Hematol. 2016 Oct 20;
[PubMed ID: 27766528]
Hafner AL Contet J Ravaud C Yao X Villageois P Suknuntha K Annab K Peraldi P Binetruy B Slukvin II Ladoux A Dani C .
Brown-like adipose progenitors derived from human induced pluripotent stem cells: Identification of critical pathways governing their adipogenic capacity. Sci Rep. 2016 Aug 31;6:32490
[PubMed ID: 27577850]
Slukvin II .
Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition. FEBS Lett. 2016 Jul 8;
[PubMed ID: 27391301]
D'Souza SS Maufort J Kumar A Zhang J Smuga-Otto K Thomson JA Slukvin II .
GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells. Stem Cell Reports. 2016 Feb 9;6(2):243-56
[PubMed ID: 26805448]
Kang H Minder P Park MA Mesquitta WT Torbett BE Slukvin II .
CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus. Mol Ther Nucleic Acids. 2015 Dec 15;4:e268
[PubMed ID: 26670276]
Elcheva I Brok-Volchanskaya V Slukvin I .
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells. J Vis Exp. 2015 Dec 3;(106):e52910
[PubMed ID: 26710184]
Suknuntha K Ishii Y Tao L Hu K McIntosh BE Yang D Swanson S Stewart R Wang JY Thomson J Slukvin I .
Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells. Stem Cell Res. 2015 Nov;15(3):678-93
[PubMed ID: 26561938]
McIntosh BE Brown ME Duffin BM Maufort JP Vereide DT Slukvin II Thomson JA .
Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Reports. 2015 Feb 10;4(2):171-80
[PubMed ID: 25601207]
Uenishi G Theisen D Lee JH Kumar A Raymond M Vodyanik M Swanson S Stewart R Thomson J Slukvin I .
Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports. 2014 Dec 9;3(6):1073-84
[PubMed ID: 25448067]
Elcheva I Brok-Volchanskaya V Kumar A Liu P Lee JH Tong L Vodyanik M Swanson S Stewart R Kyba M Yakubov E Cooke J Thomson JA Slukvin I .
Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nat Commun. 2014 Jul 14;5:4372
[PubMed ID: 25019369]
Slukvin II .
Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells. Cell Cycle. 2013 Mar 1;12(5):720-7
[PubMed ID: 23388453]
Hu K Slukvin I .
Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors. Methods Mol Biol. 2013;997:163-76
[PubMed ID: 23546755]
Choi KD Vodyanik MA Togarrati PP Suknuntha K Kumar A Samarjeet F Probasco MD Tian S Stewart R Thomson JA Slukvin II .
Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep. 2012 Sep 27;2(3):553-67
[PubMed ID: 22981233]
Slukvin II .
Epicardial origin of cardiac CFU-Fs. Cell Stem Cell. 2011 Dec 2;9(6):492-3
[PubMed ID: 22136919]
Dias J Gumenyuk M Kang H Vodyanik M Yu J Thomson JA Slukvin II .
Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 2011 Sep;20(9):1639-47
[PubMed ID: 21434814]
Slukvin II Vodyanik M .
Endothelial origin of mesenchymal stem cells. Cell Cycle. 2011 May 1;10(9):1370-3
[PubMed ID: 21444996]
Hu K Yu J Suknuntha K Tian S Montgomery K Choi KD Stewart R Thomson JA Slukvin II .
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 2011 Apr 7;117(14):e109-19
[PubMed ID: 21296996]
Salvagiotto G Burton S Daigh CA Rajesh D Slukvin II Seay NJ .
A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs. PLoS One. 2011 Mar 18;6(3):e17829
[PubMed ID: 21445267]
Choi KD Vodyanik M Slukvin II .
Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc. 2011 Mar;6(3):296-313
[PubMed ID: 21372811]
Vodyanik MA Yu J Zhang X Tian S Stewart R Thomson JA Slukvin II .
A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell. 2010 Dec 3;7(6):718-29
[PubMed ID: 21112566]